LATEST
Fri, Sep 4, 2026
Loading weather...
India

ZoeNCure Therapeutics Secures License for Novel Antibody Platform from Styx Biotechnologies to Advance Next-Generation ADCs for Liver Cancer

Strategic licensing agreement enables ZoeNCure to build a high-potency, ADC pipeline targeting severe gastrointestinal and liver cancers in India....

ZoeNCure Therapeutics Secures License for Novel Antibody Platform from Styx Biotechnologies to Advance Next-Generation ADCs for Liver Cancer
Source: The Hindu - General

Strategic licensing agreement enables ZoeNCure to build a high-potency, ADC pipeline targeting severe gastrointestinal and liver cancers in India.

SOURCE: The Hindu - General
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from India

Air India Terminates Phuket-Delhi Pilot After Psychoactive Drug Test

The announcement from the airline came hours after probe agency AAIB's prelimina...

Read Article »

Tukaram Mundhe Beats Devendra Fadnavis, Eknath Shinde On Instagram: How IAS Officer Became A Social Media Favourite

Despite sharing relatively few posts, Tukaram Mundhe's Instagram engagement sits...

Read Article »

Former Minister Talasani | ప్రజా పాలన కాదు.. కాంగ్రెస్‌ దోపిడీ పాలన : మాజీ మంత్రి తలసాని

Former Minister Talasani | ప్రజా పాలన పేరిట రాష్ట్రాన్ని దొంగల మాదిరిగా దోపిడీ ...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.